8-K
filed March 23, 2026, 7:59 PM ET
ticker AZTR
CIK 0001701478
other material
confidence high
sentiment positive
materiality 0.80
Azitra raises $10.5M initial PIPE, up to $31.4M with warrants, for cosmetic protein program
Azitra, Inc.
- Initial gross proceeds of ~$10.5M from sale of Series A preferred & warrants; potential additional ~$20.9M if warrants exercised.
- Warrants exercisable at $0.123/share; Series B warrants expire 18 months after stockholder approval; Series C upon data announcement.
- Proceeds to fund R&D for filaggrin protein/peptide cosmetic program targeting $2.3B market growing to $3.7B by 2030.
- Insiders including CEO participated; Stonepine Capital and Nantahala Capital among investors.
- Company must seek stockholder approval for conversion of preferred shares into common; registration rights agreement filed.
Key facts
Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Azitra, Inc. issued 10,485 shares of preferred stock to the Purchasers for purchase price of $1,000.00 per Security.
- Security
- preferred stock
- Shares
- 10,485 shares
- Purchaser
- the Purchasers
- Consideration
- purchase price of $1,000.00 per Security
Exact text from the filing
of Common Stock (collectively, each share of Series A Preferred Stock and Accompanying Warrants, a “Security”). The Securities are being sold at a purchase price of $1,000.00 per Security to the Purchasers, which includes the Company’s Chief Executive Officer, a consultant of the Company, and a holder of more than 5% of the Company’s outstanding Common
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Azitra, Inc. issued Series C Warrants to purchase up to 85,233,126 shares of Common Stock of warrant to the Purchasers for exercise price of $0.123 per share.
- Security
- warrant
- Shares
- Series C Warrants to purchase up to 85,233,126 shares of Common Stock
- Purchaser
- the Purchasers
- Consideration
- exercise price of $0.123 per share
Exact text from the filing
of the Company, and a holder of more than 5% of the Company’s outstanding Common Stock as of the date of the Purchase Agreement. The Warrants will each have an exercise price of $0.123 per share (the “Exercise Price”). The PIPE Financing closed on March 20, 2026 (the “Closing Date”). The PIPE Financing could result in gross proceeds of up to approximately $31.4
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Azitra, Inc. issued Series B Warrants to purchase up to 85,233,126 shares of Common Stock of warrant to the Purchasers for exercise price of $0.123 per share.
- Security
- warrant
- Shares
- Series B Warrants to purchase up to 85,233,126 shares of Common Stock
- Purchaser
- the Purchasers
- Consideration
- exercise price of $0.123 per share
Exact text from the filing
of the Company, and a holder of more than 5% of the Company’s outstanding Common Stock as of the date of the Purchase Agreement. The Warrants will each have an exercise price of $0.123 per share (the “Exercise Price”). The PIPE Financing closed on March 20, 2026 (the “Closing Date”). The PIPE Financing could result in gross proceeds of up to approximately $31.4
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Azitra, Inc.: Filed Certificate of Designations for Series A Preferred Stock (effective 2026-03-19).
- Change
- charter amendment
- Effective
- 2026-03-19
Exact text from the filing
On March 19, 2026 (the “Filing Date”), the Company filed the Certificate of Designations with the Secretary of State of the State of Delaware designating 12,000 shares of its authorized and unissued preferred stock as Series A Preferred Stock.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Azitra, Inc. entered into Securities Purchase Agreement with the purchasers named therein valued at gross proceeds of up to approximately $31.4 million (effective 2026-03-18).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- the purchasers named therein
- Value
- gross proceeds of up to approximately $31.4 million
- Effective
- 2026-03-18
Exact text from the filing
On March 18, 2026, Azitra, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the purchasers named therein (the “Purchasers”), pursuant to which the Company agreed to issue and sell an aggregate of (i) 10,485 shares of its Series A convertible non-redeemable preferred stock, par value $0.0001 per share (the “Series A Preferred Stock”), (ii) Series B warrants (the “Series B Warrants”) to purchase up to 85,233,126 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) (or, in certain circumstances, pre-funded warrants to purchase shares of Common Stock (the “Pre-Funded Warrants”)), (iii) Series C warrants to purchase up to 85,233,126 shares of Common Stock (or, in certain circumstances, Pre-Funded Warrants) (the “Series C Warrants” and, together with the Series B Warrants, the “Warrants”) to the Purchasers in a private placement (the “PIPE Financing”).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.